Vacation Time in Early September 2019 with Limited Updates.
by | Aug 31, 2019 | Biopharmaceuticals
Large Cap Biopharmaceuticals: 2019 Performance Snapshot-Can the XBI remain a good play for Q4?..Update-1.
Update-1 Aug 31 Saturday-Biotech Stocks on the Road to Nowhere? IBB flat for the week at $102.89, down 5 pts for the month. XBI flat for the week at $80.37 down 7 pts for the month. Alexion (ALXN) down 10.17% to $100.76 on patent challenge from Amgen (AMGN) on...Rayno Biobeat #2: A Wicked Week with Bearish Trends in Biopharma-Update 3.. ALXN, Trade War Talk
Update -3 Bearish trends in biopharma continue with both the IBB and XBI down with 30 min of trading to go. We will do a review of the healthcare sector later this week continuing the theme after the AACC of the need for diversification within healthcare e.g. medtech,...Red Screen Day in Biotech as Trade Tensions Trigger Bearish Sentiment…Update-Rally Day
Update-3…8/16 Big reversal day…summary this weekend with XBI up 2.65% at $82.46 just above support. Update-2… 8/14 Nowhere to hide from Global economic fears-welcome to whipsaw trading. Technicals matter not tweets. Market averages down about 3%...Biopharma Stocks Surge in a Seemingly Random Rally But Still Trail the S&P 500…Update-Risk Off
8/5… Risk OFF with Trade War and a Currency War XBI down 3.33% to $81.22, IBB down 2.65% to $102.29. WE will update later this week. Tuesday 8/6 we will attend the AACC Clinical EXPO in Anaheim CA. ======== Update-2..8/1 1:30p VRTX sparks biopharma stocks up 6%...Rayno BioBeat #1 2019: Biotech Trading Trends In a Choppy Market: Mid Year… Update-3. BIIB IWM
Update -3 …Nice biotech rally today; green screen in gene therapy and mid-cap sectors. XBI and IWM up over 1%. Update-2…Small cap reversal IWM up 1.67% to $157 level; our small cap portfolio winners: AMRN CFMS GNMK MGTX VCEL etc. but XBI still lags stuck...Can More Deals Wake Up Biotech? Laggard GILD Up 2.5% on More Galapagos Investment…Update-2 SGEN
Update-2 11:30a EDT Seattle Genetics (SGEN) revenues grow 30% , stock soars 15%.This is the way large cap biotech model is supposed to work-grow top line revenue.The Company is a leader in oncology with antibody-drug conjugates (ADC). ===== Update-1 Biopharma stocks...Vacation Week Update-Biotech Stocks…Update-1 IBB,ILMN
Update-1 11a EDT, Large cap drugs and biotechs resume slide on drug pricing “reform” from Trump threats. IBB down 1.37%, XPH in downtrend tp $38.41. Laggards holding BIB, GILD. Winners losing MRK, RHHBY. LLY and PFE hit hard. Gene therapy green: BOLD,SGMO....Gene Therapy Stocks are Big Winners in 2019: VYGR, MGTX, QURE… Update-1
Update-1 A bit of a sell-off in gene therapy but MGTX at new highs at $29.44. Profit taking on Sarepta down 3.84% to $150.59. Roche (RHHBY) and Merck (MRK) near new highs. Mid-caps mixed but Novacure (NVCR) rally 3.27% toward new highs. One of our top picks Amarin...Crazy Stealth Biotech Rally Today, IPOs Strong in Healthcare
Crazy Stealth Biotech Rally in Small Caps-Who Gave the Buy Signal? NASDAQ up 0.73%, XLV up 0.70 %. MedTech and Dx/Tools also green. IWM up 1.88% to $153.63 up 14% YTD, lagging XBI up 20.7% YTD. Volatile market for traders in small caps. It was a green screen for small...
Reuters Healthcare
- AstraZeneca diabetes drug granted fast track status for heart failure treatment September 16, 2019
- Tanzania's Zanzibar begins to register traditional healers September 16, 2019
- New York to ban flavored e-cigarettes after illnesses, deaths September 15, 2019
- Japan culls 753 hogs to contain swine fever outbreak September 15, 2019